The Vanguard Group Discloses Stake in Spire Healthcare Group

The Vanguard Group, Inc. has disclosed its position in Spire Healthcare Group plc through a Form 8.3 filing dated 30 July 2026. According to the details submitted, Vanguard controls 14,283,700 ordinary shares, representing 3.55% of the relevant securities. This disclosure is in compliance with Rule 8.3 of the Takeover Code, concerning interests in relevant securities of 1% or more.

The position held as of 29 July 2026, includes recent activity, such as the purchase of 5,030 ordinary shares at 2.34 GBP each. No additional cash-settled or stock-settled derivative positions were disclosed. Furthermore, no rights to subscribe for new securities or other contractual arrangements affecting voting rights have been reported.

This filing outlines Vanguard’s financial interest in Spire Healthcare amid ongoing market developments. No additional agreements or incentives influencing these dealings were mentioned. The disclosure comes under the supervision of Shawn Acker, contactable for further inquiries.